Recurrence of Miller-Fisher syndrome is exceptionally rare, and I only became aware of this possibility until I retrieved some relevant literature. Given its extreme rarity, and noting that the documented recurrences were primarily identified based on clinical features rather than antibody measureme...

The treatment of MFS is controversial and not addressed in the recently published guidelines. Should a patient exhibit muscle weakness beyond facial and EOM, it could imply an overlap between MFS and/or GBS. While there's limited study in this area, persistent antibodies, albeit reduced, might not s...